StockFinancial Services · INSURANCE BROKERS

$EZRA

Reliance Global Group, Inc.

Price · $EZRAvia TradingView

AI sentiment · 7d0 articles

No enriched coverage for $EZRA in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $EZRA in the last 30 days.

Reliance Global Group Expands Into Radiopharmaceuticals with Investment

Reliance Global Group announced its expansion into radiopharmaceuticals through its new subsidiary, LifeSci Global Group LLC. LifeSci Global invested approximately $2 million in Innervate Radiopharmaceuticals, a developer of PET imaging and therapeutic radiopharmaceuticals. This strategic move diversifies Reliance's portfolio beyond InsurTech, despite existing financial challenges and requires governance changes to address potential conflicts of interest.

MAR 18·TipRanks

Reliance Global Restates Governance and Extends Capital Commitment

Reliance Global Group settled legacy stock guarantee disputes for approximately $131,000 in March 2026, fully terminating related obligations. The company also expanded its equity purchase facility to $50 million and updated its bylaws and articles of incorporation, enhancing capital flexibility and corporate governance. These actions are seen as strategic progress despite persistent net losses and bearish technicals, with an AI analyst rating the stock Neutral.

via TradingView

News on $EZRA

All news →